Harvard Bioscience Stock News

Harvard Bioscience (HBIO) is a small-cap, life-science technology company that is underfollowed.

Harvard Bioscience, Inc. (HBIO) CEO James Green on Q4 2021 Results - Earnings Call Transcript

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative Options For Infectious Diseas

Harvard Bioscience press release (HBIO): Q4 Non-GAAP EPS of $0.08 misses by $0.03.Revenue of $33.1M (+6.8% Y/Y) in-line.

HOLLISTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the period ended December 31, 2021.

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE: BW ) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. • Desktop Metal (NYSE: DM ) is projected to report quarterly loss at $0.09 per share on revenue of $49.58 million. • Stevanato Group (NYSE: STVN ) is projected to report quarterly earnings at $0.11 per share on revenue of $244.99 million. • CPI Card (NASDAQ: PMTS ) is likely to report quarterly earnings at $0.35 per share on revenue of $94.40 million. • CareMax (NASDAQ: CMAX ) is likely to report quarterly loss at $0.06 per share on revenue of $118.44 million. • Matinas BioPharma Hldgs (AMEX: MTNB ) is expected to report quarterly loss at $0.03 per share on revenue of $470.00 thousand. • Nuvei (NASDAQ: NVEI ) is likely to report quarterly earnings at $0.57 per share on revenue of $264.56 million. • Gaotu Techedu (NYSE: GOTU ) is likely to report quarterly earnings at $0.26 per share on revenue of $333.80 million. • OptiNose (NASDAQ: OPTN ) is estimated to report quarterly loss at $0.

HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on

HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on Ma

Strs Ohio cut its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 7.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 97,400 shares of the medical instruments suppliers stock after selling 8,100 shares during the quarter. Strs Ohios holdings in Harvard Bioscience were worth $679,000 at the end of the most recent reporting period. []

Wells Fargo & Company MN raised its position in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 71.4% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 423,186 shares of the medical instruments suppliers stock after acquiring an additional 176,253 shares during the quarter. Wells Fargo & Company MNs holdings in Harvard Bioscience were worth $3,525,000 as []

Analysts predict that Harvard Bioscience, Inc. (NASDAQ:HBIO) will report sales of $32.65 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Harvard Biosciences earnings, with the lowest sales estimate coming in at $32.50 million and the highest estimate coming in at $32.80 million. Harvard Bioscience reported sales of $30.98 million []

Millennium Management LLC lifted its stake in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) by 144.6% during the second quarter, Holdings Channel.com reports. The firm owned 145,562 shares of the medical instruments suppliers stock after acquiring an additional 86,058 shares during the period. Millennium Management LLCs holdings in Harvard Bioscience were worth $1,213,000 as of its []

Prudential Financial Inc. purchased a new stake in Harvard Bioscience, Inc. (NASDAQ:HBIO) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,509 shares of the medical instruments suppliers stock, valued at approximately $113,000. Several other hedge funds and other institutional []